Loading...

PANACEABIO Panacea Biotec Ltd Earnings Reports Announcement

Pnc

PNCB

Panacea Biotec Ltd

(PANACEABIO)

2026 Announcement

SAST disclosure

Share demat window

Vaccine global access

SAST disclosure

Audited results publication

Dividend suspension

Independent director appoin...

Appointment of directors

Secretarial Compliance Report

Board meeting postponement

Board meeting for results

Dematerialization update

Oncology Lab Fire

Tax litigation outcome

Regulatory compliance

Labor tribunal awards

Regulatory Compliance

Dematerialisation status

Rectified IT Assessment

Rectified Assessment Order

Independent Director Cessation

Independent Director Cessation

Independent Director Resign...

Civil Litigation Update

Trading Window Closure

Tax litigation update

Tax litigation ITAT ruling

Income Tax Demand

Dematerialization Status

Income Tax Demand

Regulatory disclosure

Newspaper Publication

Standalone and Consolidated...

Board meeting outcome

Dematerialisation details

GMP non-compliance / Regula...

Phase III enrollment

Regulatory compliance certi...

Dematerialisation details

Tax demand under IT Act

Trading Window Closure

KMP appointments

KMP appointments

KMP appointments and cessat...

KMP Appointments

Share Dematerialisation

CFO Resignation

Resignation of KMP

Unaudited Standalone and Co...

Unaudited Results (Provisio...

Unaudited Results

SMP appointment

Share Dematerialization

Board Meeting Notice

Share Transfer Notice

Vaccine Supply Contract

Compliance Certificate

Demat Status Report

UNICEF Contract Award

GST Show Cause Notice

Product Launches

New Baby Products

PAN and KYC Request

AGM Notice Publication

Demat Status Report

AGM Announcement

Shareholder Notice

Financial Results Announcement

Demat Status Report

Management Change

Reclassification Approval

Share Transfer Notice

GST Demand Order

Settlement Agreement

Share Dematerialisation Update

Compliance Certificate

Share Dematerialization

Adjuvant Commercialization

Financial Results Publication

Secretarial Auditor Appoint...

Annual Compliance Report

ChilRun Study Results

Shares Dematerialized

Shares Dematerialized Update

Compliance Certificate

Management Change

Director Change

Director Change

Price Movement Clarification

Shares Dematerialized

Postal Ballot Notice

Financial Results Publication

Directorate Change

Management Changes

Leadership Change

Demat Report January 2025

Court Ruling Update

Share Dematerialization Update

Compliance Certificate

Management Change

Further Investment

UNICEF Order Award

Management Change

Shares Dematerialized Update

Postal Ballot Notice

Financial Results Released

Management Changes

Director Appointment

Share Dematerialization

Director Passing

Reclassification Application

Compliance Confirmation

Share Dematerialization Update

Auditor Appointment

Auditor Appointment

Lawsuit Settlement

KYC Compliance Reminder

Loan for Expansion

Demat Status Update

Annual Meeting Notice

Email Registration Notice

GST Demand Order

Financial Results Published

Auditor Resignation

DengiALL Trials Start

Auditor Appointment

Reclassification Update

Reclassification Request

Compliance certificate subm...

Demat Status Report

Arbitration Request

Management Change

Incorporation of Subsidiary

Demat Status Report

Financial Results Publication

Compliance Submission

Reclassification Withdrawal

Shares dematerialized

Senior Management Personnel...

Resignation Announcement

Certification Compliance

Demat Status Report

Compliance Certification

Certificate Issued

Directorate Change

Publication of Notices

Shares Dematerialized

Financial Results Published

Financial Results and Direc...

Shares Dematerialized

FDA Inspection Update

Shares Dematerialized

Compliance Certificate Subm...

Product Launches, Registration

Shares Dematerialized

Financial Results

Shares Dematerialized

Launch of Generic Version

US FDA Inspection

Other Situations

Shares Dematerialized

Arbitration Proceeding

Advertisement publication

Re-Classification Application

Shares Dematerialized

Financial Statements

Reclassification

Reclassification of Promoters

Rights Offerings

Product Expansion

Share dematerialization

Financial Results Submission

Reminder Letters

Compliance Report Submission

Financial Reports

External Links:

Data:

Board to consider and approve Panacea Biotec’s audited Q4/FY2026 results on May 29, 2026, with potential dividend decisions and a closed trading window through May 31, 2026.

AI Assistant

Panacea Biotec Ltd

2026

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.